Biogen Idec Investors
Biogen Idec is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
.jpg)
.jpg)
Estimated Revenue:
$1B to $10B
Funding Status:
IPO
Industry:
Biotechnology, Health Care, Neuroscience, Therapeutics
Acquisitions Number:
9
Number Of Exists:
15
Technology:
NeuroPharmacology
Founded Date:
1978
Investor Type:
Venture Capital
Headquarters:
Weston, Massachusetts, United States
Employee Number:
5001-10000
Investment Stage:
Early Stage Venture, Late Stage Venture